• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药代动力学/药效学建模及其在抗菌和抗真菌药物治疗中的应用:综述

Pharmacokinetic/Pharmacodynamic Modeling and Application in Antibacterial and Antifungal Pharmacotherapy: A Narrative Review.

作者信息

Pereira Laiz Campos, Fátima Marcelo Aguiar de, Santos Valdeene Vieira, Brandão Carolina Magalhães, Alves Izabel Almeida, Azeredo Francine Johansson

机构信息

Laboratory of Pharmacokinetics and Pharmacometrics, Faculty of Pharmacy, Federal University of Bahia (UFBA), Rua Barão de Jeremoabo, 147, Salvador 40170-115, BA, Brazil.

Pharmacy Graduate Program, Federal University of Bahia, Rua Barão de Jeremoabo, 147, Salvador 40170-115, BA, Brazil.

出版信息

Antibiotics (Basel). 2022 Jul 22;11(8):986. doi: 10.3390/antibiotics11080986.

DOI:10.3390/antibiotics11080986
PMID:35892376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9330032/
Abstract

Pharmacokinetics and pharmacodynamics are areas in pharmacology related to different themes in the pharmaceutical sciences, including therapeutic drug monitoring and different stages of drug development. Although the knowledge of these disciplines is essential, they have historically been treated separately. While pharmacokinetics was limited to describing the time course of plasma concentrations after administering a drug-dose, pharmacodynamics describes the intensity of the response to these concentrations. In the last decades, the concept of pharmacokinetic/pharmacodynamic modeling (PK/PD) emerged, which seeks to establish mathematical models to describe the complete time course of the dose-response relationship. The integration of these two fields has had applications in optimizing dose regimens in treating antibacterial and antifungals. The anti-infective PK/PD models predict the relationship between different dosing regimens and their pharmacological activity. The reviewed studies show that PK/PD modeling is an essential and efficient tool for a better understanding of the pharmacological activity of antibacterial and antifungal agents.

摘要

药代动力学和药效学是药理学中与药学科学不同主题相关的领域,包括治疗药物监测和药物研发的不同阶段。虽然这些学科的知识至关重要,但从历史上看,它们一直是分开对待的。药代动力学仅限于描述给药剂量后血浆浓度的时间进程,而药效学则描述对这些浓度的反应强度。在过去几十年中,药代动力学/药效学建模(PK/PD)的概念出现了,它试图建立数学模型来描述剂量-反应关系的完整时间进程。这两个领域的整合已应用于优化抗菌和抗真菌治疗的给药方案。抗感染PK/PD模型预测不同给药方案与其药理活性之间的关系。综述研究表明,PK/PD建模是更好地理解抗菌和抗真菌药物药理活性的重要且有效的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1d4/9330032/8b20c25400cc/antibiotics-11-00986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1d4/9330032/bd3176fca10a/antibiotics-11-00986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1d4/9330032/8b20c25400cc/antibiotics-11-00986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1d4/9330032/bd3176fca10a/antibiotics-11-00986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1d4/9330032/8b20c25400cc/antibiotics-11-00986-g002.jpg

相似文献

1
Pharmacokinetic/Pharmacodynamic Modeling and Application in Antibacterial and Antifungal Pharmacotherapy: A Narrative Review.药代动力学/药效学建模及其在抗菌和抗真菌药物治疗中的应用:综述
Antibiotics (Basel). 2022 Jul 22;11(8):986. doi: 10.3390/antibiotics11080986.
2
Pharmacokinetic/pharmacodynamic modeling in drug research and development.药物研发中的药代动力学/药效学建模
J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1399-418.
3
Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision.对抗日益严重的抗微生物药物耐药性:最大精度的药代动力学/药效学给药策略。
Int J Antimicrob Agents. 2021 Mar;57(3):106269. doi: 10.1016/j.ijantimicag.2020.106269. Epub 2020 Dec 23.
4
Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.重度烧伤成人患者静脉用抗生素和抗真菌药物的药代动力学-药效学给药方案
Clin Ther. 2016 Sep;38(9):2016-31. doi: 10.1016/j.clinthera.2016.08.001. Epub 2016 Aug 30.
5
Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.新生儿和婴儿最常用的抗菌药、抗真菌药和抗病毒药的药代动力学和药效学
Clin Pharmacokinet. 2014 Jul;53(7):581-610. doi: 10.1007/s40262-014-0147-0.
6
Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.药代动力学/药效学(PK/PD)建模的基本概念。
Int J Clin Pharmacol Ther. 1997 Oct;35(10):401-13.
7
Population pharmacodynamic and pharmacokinetic modeling via mixed effects.通过混合效应进行群体药效学和药代动力学建模。
Curr Opin Drug Discov Devel. 2000 May;3(3):314-30.
8
Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.药代动力学/药效学(PK/PD)关系的建模:概念与展望。
Pharm Res. 1999 Feb;16(2):176-85. doi: 10.1023/a:1011907920641.
9
Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.大鼠中吗啡药代动力学-药效学模型中伤害性刺激模式相关的差异。
Pharmacol Biochem Behav. 2006 Oct;85(2):464-73. doi: 10.1016/j.pbb.2006.09.016. Epub 2006 Nov 27.
10
Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape.制药行业的临床前药代动力学/药效学建模与模拟:IQ联盟对当前现状的调查
AAPS J. 2015 Mar;17(2):462-73. doi: 10.1208/s12248-014-9716-2. Epub 2015 Jan 29.

引用本文的文献

1
Grand challenge in antibiotic pharmacology: A major step toward tailored antimicrobial treatment in very complex clinical scenarios of infectious risk management.抗生素药理学的重大挑战:在感染风险管理的非常复杂的临床场景中迈向个性化抗菌治疗的重要一步。
Front Antibiot. 2022 Sep 20;1:1016760. doi: 10.3389/frabi.2022.1016760. eCollection 2022.
2
Special Issue "Computer-Aided Drug Discovery and Treatment".特刊“计算机辅助药物发现与治疗”。
Int J Mol Sci. 2024 Feb 26;25(5):2683. doi: 10.3390/ijms25052683.
3
gPKPDviz: A flexible R shiny tool for pharmacokinetic/pharmacodynamic simulations using mrgsolve.

本文引用的文献

1
A pharmacokinetic-pharmacodynamic (PKPD) model-based analysis of tedizolid against enterococci using the hollow-fibre infection model.基于药代动力学-药效学(PKPD)模型的替加环素对肠球菌的空心纤维感染模型分析。
J Antimicrob Chemother. 2022 Aug 25;77(9):2470-2478. doi: 10.1093/jac/dkac183.
2
Pharmacokinetic/pharmacodynamic-guided gentamicin dosing in critically ill patients: a revisit of the Hartford nomogram.基于药代动力学/药效学的重症患者庆大霉素给药方案:重新审视哈特福德列线图。
Int J Antimicrob Agents. 2022 Jun;59(6):106600. doi: 10.1016/j.ijantimicag.2022.106600. Epub 2022 May 6.
3
Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against and in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles?
gPKPDviz:一个使用 mrgsolve 进行药代动力学/药效学模拟的灵活 R shiny 工具。
CPT Pharmacometrics Syst Pharmacol. 2024 Mar;13(3):341-358. doi: 10.1002/psp4.13096. Epub 2023 Dec 26.
4
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A Review.EMA 批准的抗真菌药物研发过程中的临床前药代动力学/药效学研究和临床试验:综述。
Clin Pharmacokinet. 2024 Jan;63(1):13-26. doi: 10.1007/s40262-023-01327-2. Epub 2023 Nov 16.
5
A data-driven machine learning approach for discovering potent LasR inhibitors.基于数据驱动的机器学习方法发现强效 LasR 抑制剂。
Bioengineered. 2023 Dec;14(1):2243416. doi: 10.1080/21655979.2023.2243416.
6
Bayesian model-guided antimicrobial therapy in pediatrics.儿科中的贝叶斯模型引导抗菌治疗
Front Pharmacol. 2023 Jun 22;14:1118771. doi: 10.3389/fphar.2023.1118771. eCollection 2023.
7
Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant in an In Vitro Cystic Fibrosis Sputum Model.在体外囊性纤维化痰液模型中,德拉氟沙星和对照氟喹诺酮类药物对多重耐药菌的活性。
Antibiotics (Basel). 2023 Jun 20;12(6):1078. doi: 10.3390/antibiotics12061078.
8
Safety and Tolerability of Antimicrobial Agents in the Older Patient.老年患者中抗菌药物的安全性和耐受性。
Drugs Aging. 2023 Jun;40(6):499-526. doi: 10.1007/s40266-023-01019-3. Epub 2023 Mar 28.
成人侵袭性真菌病患者中艾沙康唑对烟曲霉和黄曲霉的群体药代动力学及药效学靶点达标情况:艾沙康唑的治疗药物监测是否应像其他抗霉菌活性唑类药物一样被视为强制性的?
Pharmaceutics. 2021 Dec 6;13(12):2099. doi: 10.3390/pharmaceutics13122099.
4
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.基于模型的抗感染药物研发:现状与未来。
Clin Pharmacol Ther. 2021 Apr;109(4):867-891. doi: 10.1002/cpt.2198. Epub 2021 Mar 9.
5
Model-Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin.抗菌药物的模型指导药物研发:通过转化药代动力学和药代动力学/药效学模型预测大观霉素在人体中的有效剂量。
Clin Pharmacol Ther. 2021 Apr;109(4):1063-1073. doi: 10.1002/cpt.2104. Epub 2020 Nov 28.
6
Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges.药代动力学-药效学模型在药物递送中的应用:发展与挑战
Front Pharmacol. 2020 Jul 3;11:997. doi: 10.3389/fphar.2020.00997. eCollection 2020.
7
How preclinical infection models help define antibiotic doses in the clinic.临床前感染模型如何帮助确定临床抗生素剂量。
Int J Antimicrob Agents. 2020 Aug;56(2):106008. doi: 10.1016/j.ijantimicag.2020.106008. Epub 2020 May 7.
8
Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It.革兰氏阴性菌对抗菌药物的耐药性及其解决方法。
Molecules. 2020 Mar 16;25(6):1340. doi: 10.3390/molecules25061340.
9
A pharmacometric approach to define target site-specific breakpoints for bacterial killing and resistance suppression integrating microdialysis, time-kill curves and heteroresistance data: a case study with moxifloxacin.应用微透析技术、时间杀菌曲线和异质性耐药数据,通过药物代谢动力学方法定义靶向杀菌和耐药抑制的目标部位断点:以莫西沙星为例的研究
Clin Microbiol Infect. 2020 Sep;26(9):1255.e1-1255.e8. doi: 10.1016/j.cmi.2020.02.013. Epub 2020 Feb 21.
10
Semi-mechanistic PK/PD modelling of combined polymyxin B and minocycline against a polymyxin-resistant strain of Acinetobacter baumannii.多黏菌素 B 和米诺环素联合治疗对鲍曼不动杆菌耐药株的半机械性 PK/PD 模型研究。
Clin Microbiol Infect. 2020 Sep;26(9):1254.e9-1254.e15. doi: 10.1016/j.cmi.2020.01.017. Epub 2020 Jan 30.